DOI:

EAPCI membership: converging worlds and techniques

William Wijns*, President, EAPCI

An association grows strong for many reasons: the quality of its offerings, the underlying validity of its existence, and above all, the members it has brought in.

Today there are over 10,000 of you receiving this journal... more than 10,000 potential members of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), an integral part of the European Society of Cardiology (ESC) – an Association whose official publication you are now reading and which is open to all those who can honestly declare that “percutaneous cardiovascular intervention is your primary activity or interest”. And yet today, with so much recognised potential, our still young EAPCI only counts a little over 1,400 of you as members. Why? The benefits are many, and have been mentioned before and can be best consulted at our dedicated website (www.escardio.org/bodies/associations/EAPCI/) where you will find information not only on membership itself, but on our training and research fellowship programmes, as well as the upcoming meetings.

The EAPCI is open to all professionals whether you are PCI doctors, valvular specialists, cath lab nurses and technicians, non-cardiologists who are performing these procedures such as surgeons, radiologists or angiologists as well as researchers or doctors working in the device industry – all of you are eligible.

Membership benefits are manifold, and the areas of interest of the young EAPCI are constantly evolving through member participation. If we look at our current membership data, as of mid-February, we had 1,409 members – and while you can only vote if you are resident in one of the 50 official ESC member states – 93 countries throughout the world are represented. If we look at these numbers in a little detail, they are revealing of a number of trends, first a growing interest within Europe in our association, and second, the emergence of Asia as a centre of interest, not just for us, but – by their very active participation in the EAPCI – in what we are doing here in Europe.

An international presence

Italy has the most participants with well over 100, followed closely by Poland and Spain which have over a hundred members as well. The U.K., Germany and France are close behind with between 50 and 100 members each, while other European countries such as Greece, The Netherlands and Belgium are fast approaching the 50 mark. Switzerland, Serbia, Romania and the Czech Republic are all represented with substantial participation, while there are now members from just about every European nation, including the Russian Federation.

Outside of Europe, our worldwide membership is of great interest to us, and strengthens our determination to grow. India and Iran have over 60 members each. The Mediterranean basin and the Near East – with Egypt (54 members), Turkey (45 members), Israel (41 members), Saudi Arabia (12), Libya (10), Jordan (10), Syria (8), Lebanon (8), Tunisia (7), United Arab Emirates (6), Yemen and Algeria (2) – are very active. Moving farther east Pakistan and Iraq all largely participate as well. Other regions of Africa are present with members from South Africa to Mauritius and Sudan; Central and South America are represented, with Brazil being the most represented of all these countries.

It is of course not surprising that North America is well represented with membership from Mexico to Canada, but what is very interesting to us, from our standpoint in the speciality, but also as Europeans, is that we have as many members in the United States as we now do in China. And if we add up all the other Pacific rim and East Asian nations that have joined the EAPCI to this date (and not including that very large participation from India we mentioned above), we have more members from this region than we do from South or North America (and for that matter, some areas of Europe): from Thailand (which has more members than either the US or China) down to Australia and New Zealand we have more than 80 members in this part of the world today, and growing. And we are sure that, for instance, in countries such as Japan, there are many more potential members who are not aware that they can become part of the EAPCI.

Joining together

What does all this mean? That we have room to grow, certainly, that we have even more reasons to urge you to join, absolutely, because together we have far more influence than each of us alone and together we can make a true difference in the evolution of our practice.

We strongly believe that advancement requires collaboration and teamwork and a strong commitment to being inclusive – open to all that might pertain to achieving our goals of improved care and practice. This is true both for interventionalists specifically and for medicine and healthcare in general. While this might all seem obvious, and just mere rhetoric, it can have a real impact by the work we do as a group. Becoming an active member of an association such as the EAPCI, which is firmly based in Europe, committed to advancing medical education and healthcare – and at the same time has a clear international vision – is just one concrete way of making these words reality. There is a certain force in involvement and organisation. The more we are, the more influence we have over our educational offerings, our accreditation, and our viability as players in the increasingly bureaucratic game of healthcare. And we cannot emphasize enough how much you are all welcome in the EAPCI, all you who work in our field – from surgeons to radiologists, cath lab nurses and technicians, industry researchers and doctors... all of you and from every country have a role to play in our association.

A decade ago, as the computer age entered the mature stage that we know today, the term on everybody’s lips was convergence. Convergence between images and idea, between what at the time were the separate domains of video and television and the computer itself. Today, with the vast developments in technique and understanding in medicine and fast advances in certain specialities we are starting to see another such convergence, a convergence between the different specialities themselves, as well as a convergence of skills and cultures. Today we know that this advancement requires, more than ever before, not only vision, but a group effort which can only be strengthened by the kind of participation that associations such as our own represents.

We encourage interaction and exchange, we grow by working together. Become part of our world, your world and join the EAPCI.

Volume 3 Number 5
Mar 20, 2008
Volume 3 Number 5
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al

Original Research

10.4244/EIJ-D-25-01268 Jun 1, 2026
Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry
Tarantini G et al

Research Correspondence

10.4244/EIJ-D-25-01160 Jun 1, 2026
First-in-human experience with a heterotopic cross-caval transcatheter tricuspid valve replacement
Estevez-Loureiro R et al

Original Research

10.4244/EIJ-D-26-00416 May 21, 2026
Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study
Volleberg R et al
Trending articles
87.2

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
34.8

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
20.75

Flashlight

10.4244/EIJ-D-25-01014 Apr 6, 2026
Stent retriever-assisted coronary thrombectomy with continuous aspiration
Liabot Q et al
open access
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
19

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved